Training & Education
Education also is an important part of our mission. The CNBS is an integral part of the NIH-supported Research Training in Cognitive Neurology Program, a joint venture of the Behavioral Neurology Unit at Beth Israel Deaconess Medical Center and the Faculty of Arts and Sciences at Harvard University. The program spans up to three years and consists of a combination of course work in clinical resrearch, cognitive neuroscience, brain mapping techniques, transcranial magentic stimulation, clinical training in cognitive and behavioral neurology, and hands on research. The course work takes place at the Harvard School of Public Health, Harvard University, The Martinos Center for Biomedical Imaging, Youville Hospital, Dartmouth College, and the Beth Israel Deaconess Medical Center. For more information click here.
Intensive Course in Transcranial Magnetic Stimulation
CNBS offers a one-week long intensive course in non-invasive brain stimulation three times per year. The Mini-Fellowship is conducted in small groups with formal teaching sessions and ample practical exposure offering a unique opportunity for hands-on learning of the basic principles, standards of use, and potential applications of TMS in clinical neurophysiology, cognitive neuroscience, neurology, and psychiatry. At the end of the course participants will have learned and directly experienced how to determine motor threshold, how to record motor evoked potentials, how to conduct cortical mapping, silent period, input-output curve, and paired-pulse TMS studies, and how to safely apply repetitive TMS. Participants will have also learned how to design TMS studies, write TMS protocols and interpret findings of TMS studies. For more information, please contact Jared Horvath at jhorvat2@bidmc.harvard.edu.
*NEW COURSE*
An Introduction to the Clinical Practice of Transcranial Magnetic Stimulation (TMS)
Transcranial magnetic stimulation (TMS) has been a valuable neurophysiologic tool for nearly 25 years. Applications in research and clinic have grown rapidly. Recently, the FDA approved the NeuroStar TMS System for the treatment of medication refractory depression. Since this approval, the Neuronetics Company (maker of the NeuroStar System) has opened an astounding 150 TMS clinics in the US alone. Now, more than ever, it is imperative for clinicians and technicians be well versed in the safe application of TMS protocols and the appropriate measures needed to ensure patient safety. However, suitable training courses that provide technicians and clinicians with sound, unbiased training on the proper application of TMS are lacking. The intent of this two-day intensive course is two-fold. First, we will introduce emerging technicians to the TMS technology and devices, including the FDA approved NeuroStar TMS System, along with the necessary tools and materials needed on-hand for the safe application of TMS and the protection of patients. Second, we will walk emerging technicians through the proper pre-treatment screening/analysis protocols, FDA approved on-label therapeutic procedures, and post-treatment patient monitoring/continued safety assurances (according to the Guidelines and Recommendations for TMS Safety as determined by the International Federation of Clinical Neurophysiology). For more information, please contact Jared Horvath at jhorvat2@bidmc.harvard.edu.
*NEW COURSE*
Introduction to Transcranial Direct Current Stimulation (tDCS) in Neuropsychiatric Research
tDCS is a technique of noninvasive brain stimulation with strong potentiality in the field of medical and neuroscientific research. tDCS was first established in neuroscience research in the 1950’s and 60’s, but has seen a rapid growth particularly in the last 5 years. The intent of this 1-day intensive is to familiarize students with the fundamentals of the theoretical and practical aspects of tDCS. The theoretical considerations will include lectures on safety, mechanisms of action, and previous application in research settings. The practical considerations will include sessions on device set-up and parameters for experimental utilization. Regulatory aspects of the use of tDCS in research will also be addressed. For more information, please contact Jared Horvath at jhorvat2@bidmc.harvard.edu.
|
